Graham Capital Management, L.P. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,483
-69.2%
30,077
-63.2%
0.00%
-66.7%
Q2 2023$105,399
+606.1%
81,705
+622.5%
0.00%
Q1 2023$14,926
-98.6%
11,308
-98.8%
0.00%
-100.0%
Q3 2022$1,103,000
+705.1%
935,294
+668.8%
0.04%
+633.3%
Q2 2022$137,000
-83.9%
121,652
-57.3%
0.01%
-79.3%
Q1 2022$851,000
+285.1%
284,858
+241.2%
0.03%
+222.2%
Q4 2021$221,00083,4900.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders